Fluidigm Corporation (NASDAQ:FLDM) today announced its financial results for the fourth quarter and full year ended December 31, 2014.
Total revenue for the fourth quarter of 2014 was $33.5 million, an increase of 60% from $20.9 million in the fourth quarter of 2013. Organic revenue for the fourth quarter of 2014 (excluding revenue attributable to the DVS Sciences acquisition, comprised of the CyTOF® 2 system and proteomics analytical consumables) was $25.2 million, an increase of 21% from $20.9 million in the fourth quarter of 2013. Net loss for the fourth quarter of 2014 was $10.9 million, compared to a net loss of $4.6 million in the fourth quarter of 2013.
Help employers find you! Check out all the jobs and post your resume.
